ArticleBMC ophthalmology2025
Original research: factors related to persistent amblyopia after surgical correction in unilateral congenital blepharoptosis.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundManaging unilateral congenital blepharoptosis is challenging, because it is difficult to ensure symmetry under general anesthesia, and some children suffer from persistent amblyopia even after surgical correction. This study aimed to evaluate the risk factors associated with persistent amblyopia and to develop a risk stratification score for predicting persistent amblyopia in children who underwent surgical correction for unilateral congenital blepharoptosis.
methodsThis retrospective cohort study consecutively included 226 patients under the age of 12 years who underwent surgical correction for unilateral congenital blepharoptosis at Linkou Chang Gung Memorial Hospital between January 1, 2006, and December 31, 2022. Patients who still had amblyopia in the ptotic eye after individualized amblyopia treatment and ptosis surgery, with at least one year of follow-up, were classified as the persistent amblyopia group. All others were classified as the non-amblyopia group. Data collected included demographic information, age at surgery, surgical method, presence of strabismus, refraction errors, baseline amblyopia, and visual outcomes. These variables were compared between the two groups and used to predict persistent amblyopia.
resultsAmong the 226 eyes studied, persistent amblyopia was observed in 58 eyes (25.7%) after at least one year of follow-up. Factors significantly associated with persistent amblyopia included age at surgery (under 36 months or over 72 months) (p = 0.004), presence of strabismus (p = 0.001), baseline amblyopia (p < 0.001), and higher baseline astigmatism (p = 0.004). Risk stratification scores based on these variables indicated that patients in the high-risk group had a prevalence of persistent amblyopia of 61%, compared to 42% in the intermediate-risk group and only 6% in the low-risk group.
conclusionsPersistent amblyopia in children with unilateral congenital blepharoptosis is influenced by multiple factors including age at surgery, presence of strabismus, baseline amblyopia, and astigmatism. Identifying these risk factors can help in stratifying high risk patients and guiding preventative recommendations.
trial registrationThe present study was approved by the Institutional Review Board of Chang Gung Memorial Hospital (IRB No.: 202402306B0) and was conducted in accordance with the Declaration of Helsinki.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.